Philippe Froguel
From Wikipedia, the free encyclopedia
Philippe Froguel (born 14 April 1958) is a French physician and scientist who serves as chair in Genomic Medicine in the Department of Metabolism, Digestion and Reproduction at Imperial College London.[1] His research has focused on the genetics of human diseases such as obesity and type 2 diabetes. This includes research identifying the genes glucokinase and HNF1 risk factors for type 2 diabetes. In 2007, he was elected to the Academy of Medical Sciences (UK).[2] In 2017, he was elected corresponding member of the French Académie Nationale de Médecine, and he is also a member of the Mexican National Academy of Medicine (Academia Nacional de Medicina de México).[3]
Philippe Froguel | |
|---|---|
 Froguel in 2019 | |
| Born | 14 April 1958 Paris, France |
| Education | |
| Awards | Minkowski Prize (1997) |
Froguel received his M.D. from Pierre and Marie Curie University and his Ph.D. from Paris Diderot University.[4]
Awards
In 1997 Froguel was awarded the Minkowski Prize by the European Association for the Study of Diabetes, for his work on the genetics of type 2 diabetes.[5]
